Tenaya Therapeutics, Inc. (TNYA)
0.389
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.3897
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics EPS Diluted (Quarterly) : -0.1994 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1994 |
| March 31, 2026 | -0.0889 |
| December 31, 2025 | -0.1152 |
| September 30, 2025 | -0.1241 |
| June 30, 2025 | -0.143 |
| March 31, 2025 | -0.2445 |
| December 31, 2024 | -0.2759 |
| September 30, 2024 | -0.2975 |
| June 30, 2024 | -0.3434 |
| March 31, 2024 | -0.398 |
| December 31, 2023 | -0.4381 |
| September 30, 2023 | -0.3942 |
| June 30, 2023 | -0.4533 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4342 |
| December 31, 2022 | -0.6066 |
| September 30, 2022 | -0.7422 |
| June 30, 2022 | -0.6875 |
| March 31, 2022 | -0.7525 |
| December 31, 2021 | -0.6333 |
| September 30, 2021 | -0.4424 |
| June 30, 2021 | -0.3685 |
| March 31, 2021 | -0.3185 |
| December 31, 2020 | -0.25 |
| September 30, 2020 | -0.2503 |
| June 30, 2020 | -0.2123 |
| March 31, 2020 | -0.2201 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.39M |
| Revenue (Quarterly) | 1.11M |
| Total Expenses (Quarterly) | 44.50M |
| Enterprise Value | 13.09M |
| Gross Profit Margin (Quarterly) | -52.97% |
| Profit Margin (Quarterly) | -3.91K% |
| Earnings Yield | -135.6% |
| Normalized Earnings Yield | -116.48 |